Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0024 EUR | +4.35% | +4.35% | -52.94% |
Apr. 25 | European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading | MT |
Apr. 25 | Top Premarket Decliners | MT |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 91.84 | 62.22 | 7.534 | 3.635 | 2.746 | - | - |
Enterprise Value (EV) 1 | 91.84 | 62.22 | 7.534 | 3.635 | 2.746 | 2.746 | 2.746 |
P/E ratio | -3.29 x | -1.9 x | - | - | - | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | 0.6 x | 0.15 x | 0.08 x |
EV / Revenue | - | - | - | - | 0.6 x | 0.15 x | 0.08 x |
EV / EBITDA | - | - | -0.33 x | - | -0.22 x | -0.49 x | 0.81 x |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 99,720 | 125,718 | 163,775 | 712,819 | 1,144,342 | - | - |
Reference price 2 | 0.9210 | 0.4949 | 0.0460 | 0.005100 | 0.002300 | 0.002300 | 0.002300 |
Announcement Date | 3/12/21 | 4/7/22 | 4/19/23 | 4/8/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 4.6 | 18.2 | 35 |
EBITDA 1 | - | - | -22.79 | - | -12.5 | -5.6 | 3.4 |
EBIT 1 | - | -26.82 | -23.27 | -14.33 | -12.5 | -5.6 | 3.4 |
Operating Margin | - | - | - | - | -271.74% | -30.77% | 9.71% |
Earnings before Tax (EBT) 1 | - | -31.25 | -24.22 | -17.03 | -17.5 | -8.6 | 0.4 |
Net income 1 | -17.05 | -31.25 | -24.22 | -17.03 | -17.5 | -8.6 | 0.4 |
Net margin | - | - | - | - | -380.43% | -47.25% | 1.14% |
EPS | -0.2800 | -0.2600 | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 3/12/21 | 4/7/22 | 4/19/23 | 4/8/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - |
EBITDA | - | - | -11.77 | -11.02 | -6.268 | - |
EBIT | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | -18 | -12.4 | -11.82 | -7.764 | - |
Net income | -15.86 | -18 | -12.4 | -11.82 | -7.764 | - |
Net margin | - | - | - | - | - | - |
EPS | -0.1400 | -0.1400 | -0.0800 | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/17/21 | 4/7/22 | 1/31/23 | 4/19/23 | 9/27/23 | 4/8/24 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 3/12/21 | 4/7/22 | 4/19/23 | 4/8/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-52.94% | 2.81M | |
-2.87% | 103B | |
+1.39% | 95.28B | |
+1.46% | 22.15B | |
-16.15% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.36% | 16.05B | |
+4.82% | 13.68B | |
+33.11% | 12.17B |
- Stock Market
- Equities
- ALBPS Stock
- Financials Biophytis S.A.